All News #Library
Rare Diseases
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201
20 Mar 2024 //
GLOBENEWSWIRE
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201
01 Feb 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support